Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tuberculosis

TB046 – A study to help develop TB vaccines.

If you are aged 18-65, in good health, with or without type 2 diabetes, and have previously received the BCG vaccine, you may be eligible to participate.

The study involves up to 10 visits over a period of around 6 months.

Participants will be reimbursed for their time and travel up to £1095

For more information please use the following link.

 

 

LIMBO-TB – A study to help understand more about how the body fights off TB.

If you are aged 18-65, in good health, you may be eligible to participate.

The study involves 2 visits over a period of around 3 months.

Participants will be reimbursed for their time and travel up to £100 

For more information please use the following link

 

Malaria

VAC096 – Malaria vaccine study.

If you are 18-50 years old and in good health you may be eligible to participate. The study involves 17-20 visits over a period of around 12-24 months.

Participants will be reimbursed for their time and travel.

For more information please use the following link.

 

Neomivac001

New study on mRNA vaccine against COVID-19

Using a newly developed mRNA vaccine by NeoVac Ltd., researchers at the Jenner Institute at University of Oxford are conducting a study for a new vaccine against Omicron SARS-CoV 2 B.1.1.529. The vaccine is called NeomiVac.

The information gained from this study will contribute to the development of further safe and effective vaccines for future COVID-19 variants of concern as well as other diseases.

If you are 18-64 years old, you may be eligible to participate.

You will be compensated approximately £975 for your time, travel and inconvenience.

For more information please use the following link.

 

COVCHIM02

COVCHIM02 – COVID-19 Challenge Study.

If you are 18-40 years old you may be eligible to participate. The study involves 4 visits and a 17 day stay in a quarantine unit over a period of around 6 months.

You will be given the virus that causes COVID-19 in order to better understand it. Participants will be reimbursed approximately £4,935 for their time and travel.

For more information please use the following link.

 

 

Would you like to keep up to date with trials?

If you would like to register with us to receive our monthly email newsletter detailing our latest trials looking for volunteers, please click here.